Research location
Tampico
Tamaulipas, Mexico
Advertisement
Research activity in Tampico
Tamaulipas, MexicoCureCurrent currently publishes aggregate city-level research activity for this location: 12 trials and 12 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Tampico
12 linked trials · page 1 of 1Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation
RECRUITING
A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or BothNCT05260021 · 2022-04-13 · 1 site observation
COMPLETED
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 DiabetesNCT03740919 · 2019-04-07 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular RiskNCT03730662 · 2018-11-20 · 1 site observation
COMPLETED
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 DiabetesNCT02963766 · 2016-12-29 · 1 site observation
COMPLETED
Bexagliflozin Efficacy and Safety TrialNCT02558296 · 2015-10-01 · 1 site observation
COMPLETED
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 DiabetesNCT01541215 · 2012-11-13 · 1 site observation
COMPLETED
Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetesNCT01272219 · 2011-06-01 · 1 site observation
COMPLETED
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes MellitusNCT01007097 · 2009-12-01 · 1 site observation
COMPLETED
An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release TabletsNCT00643851 · 2008-06-01 · 1 site observation
COMPLETED
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin AloneNCT00528879 · 2007-09-01 · 1 site observation
COMPLETED
A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionNCT00696384 · 2007-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.